Clinical Trial Update: Cognitive and Neural Effects of ARA290 [Phase 1, Phase 2]

View source ↗

Summary

This update reports on the completion of Phase 1 and Phase 2 trials evaluating cognitive and neural effects of ARA290 in depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• ARA290

Snippet

Sponsor: Leiden University Medical Center | Conditions: Depression | Phase 1, Phase 2 | Status: COMPLETED